Maria J. Crespo
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Maria J. Crespo has a total of 53 co-authors. Here are the top co-authors by number of shared publications:
Hector Torres
Anesthesiology, University of Puerto Rico, Medical Sciences Campus, San Juan, PRI
6 shared publicationsMarie Román
Department of Anesthesiology, University of Puerto Rico School of Medicine, San Juan, Puerto Rico
4 shared publicationsHarold L Rivera-Alvarado
Anesthesiology, University of Puerto Rico School of Medicine, San Juan, PRI
3 shared publicationsJose Quidgley
Department of Physiology, University of Puerto Rico-School of Medicine, San Juan, PR, USA
3 shared publicationsMyrna Morales
Department of Anesthesiology, University of Puerto Rico-School of Medicine, San Juan, USA
3 shared publicationsNildris Cruz
Department of Physiology, School of Medicine, University of Puerto Rico, San Juan, Puerto Rico
3 shared publications
Latest Publications
- Open Access
- 10 September 2026
- Published by Springer Nature in Cureus
- Vol. 18 (9) , e116044
Perioperative Anesthetic Considerations for Temporal Bone Tumor Resection in Fibroblast Growth Factor 23 (FGF23)-Related Tumor-Induced Osteomalacia: A Case Report
Phosphaturic mesenchymal tumors (PMTs) are uncommon, predominantly benign neoplasms frequently associated with dysregulated phosphate metabolism through the overproduction of fibroblast growth factor 23 (FGF23). Elevated levels of FGF23 lead to phosphate depletion, which may impair tissue oxygen delivery, central respiratory drive, and respiratory muscle function. Systemic manifestations may include osteomalacia and neuromuscular dysfunction, with an increased risk of respiratory and cardiovascular complications. PMTs often present with nonspecific clinical findings and may remain unrecognized during the perioperative period, presenting significant challenges for anesthetic planning and management. We report the case of a 72-year-old male with tumor-induced osteomalacia (TIO), a right temporal mass, and multiple comorbidities, including hypertension and obstructive sleep apnea. The patient reported progressive headaches and general weakness. After neurosurgical evaluation, he underwent elective surgical excision under general anesthesia. Intraoperatively, he developed hypotension following induction of anesthesia, requiring vasopressor support with ephedrine boluses and a continuous phenylephrine infusion. The remainder of the procedure was uneventful, and the patient was extubated and transferred to the intensive care unit in stable condition. This case highlights the importance of recognizing potential complications in patients with metabolic abnormalities presenting with PMTs, particularly disturbances in phosphate homeostasis that may have significant anesthetic implications. The use of video laryngoscopy, judicious administration of neuromuscular blocking agents, and an individualized anesthetic strategy facilitated secure airway management, minimized cervical manipulation, and supported an uneventful recovery. Moreover, integrating anesthetic selection with comprehensive perioperative planning is essential to address the metabolic, musculoskeletal, respiratory, and hemodynamic challenges associated with TIO, particularly in patients with significant comorbidities.
- 10 September 2026
- Published by Springer Nature in Cureus
- Vol. 18 (9) , e116044
Open AccessPerioperative Anesthetic Considerations for Temporal Bone Tumor Resection in Fibroblast Growth Factor 23 (FGF23)-Related Tumor-Induced Osteomalacia: A Case Report
Phosphaturic mesenchymal tumors (PMTs) are uncommon, predominantly benign neoplasms frequently associated with dysregulated phosphate metabolism through the overproduction of fibroblast growth factor 23 (FGF23). Elevated levels of FGF23 lead to phosphate depletion, which may impair tissue oxygen delivery, central respiratory drive, and respiratory muscle function. Systemic manifestations may include osteomalacia and neuromuscular dysfunction, with an increased risk of respiratory and cardiovascular complications. PMTs often present with nonspecific clinical findings and may remain unrecognized during the perioperative period, presenting significant challenges for anesthetic planning and management. We report the case of a 72-year-old male with tumor-induced osteomalacia (TIO), a right temporal mass, and multiple comorbidities, including hypertension and obstructive sleep apnea. The patient reported progressive headaches and general weakness. After neurosurgical evaluation, he underwent elective surgical excision under general anesthesia. Intraoperatively, he developed hypotension following induction of anesthesia, requiring vasopressor support with ephedrine boluses and a continuous phenylephrine infusion. The remainder of the procedure was uneventful, and the patient was extubated and transferred to the intensive care unit in stable condition. This case highlights the importance of recognizing potential complications in patients with metabolic abnormalities presenting with PMTs, particularly disturbances in phosphate homeostasis that may have significant anesthetic implications. The use of video laryngoscopy, judicious administration of neuromuscular blocking agents, and an individualized anesthetic strategy facilitated secure airway management, minimized cervical manipulation, and supported an uneventful recovery. Moreover, integrating anesthetic selection with comprehensive perioperative planning is essential to address the metabolic, musculoskeletal, respiratory, and hemodynamic challenges associated with TIO, particularly in patients with significant comorbidities.
- Open Access
- 29 March 2026
- Published by Springer Nature in Cureus
- Vol. 18 (3)
Anesthetic Challenges in Debulking Surgery of Massive Plexiform Neurofibroma With Neurofibromatosis Type 1: A Case Report of Intraoperative Generalized Involuntary Movements and Severe Blood Loss
Neurofibromatosis type 1 is a multisystem genetic disorder commonly associated with plexiform neurofibromas, benign but highly vascular tumors that present significant perioperative challenges. Surgical debulking of plexiform neurofibromas is often associated with difficult anesthetic management due to tumor vascularity, hemorrhage risk, airway considerations, and the need for intraoperative neurophysiological monitoring. We report the case of a 48-year-old man with neurofibromatosis type 1 who underwent debulking of a large right thigh plexiform neurofibroma under general anesthesia without neuromuscular blockade. The intraoperative course was notable for significant blood loss requiring transfusion and the development of transient generalized involuntary movements temporally associated with deep tumor manipulation. Despite these challenges, the procedure was successfully completed. This case highlights the anesthetic complexity of massive plexiform neurofibroma resection and underscores the importance of maintaining a broad differential diagnosis for intraoperative seizure-like phenomena in patients without epilepsy or intracranial pathology. Meticulous planning, multidisciplinary communication, and individualized anesthetic strategies are essential to optimize safety in complex neurofibromatosis type 1-related surgical procedures.
- 29 March 2026
- Published by Springer Nature in Cureus
- Vol. 18 (3)
Open AccessAnesthetic Challenges in Debulking Surgery of Massive Plexiform Neurofibroma With Neurofibromatosis Type 1: A Case Report of Intraoperative Generalized Involuntary Movements and Severe Blood Loss
Neurofibromatosis type 1 is a multisystem genetic disorder commonly associated with plexiform neurofibromas, benign but highly vascular tumors that present significant perioperative challenges. Surgical debulking of plexiform neurofibromas is often associated with difficult anesthetic management due to tumor vascularity, hemorrhage risk, airway considerations, and the need for intraoperative neurophysiological monitoring. We report the case of a 48-year-old man with neurofibromatosis type 1 who underwent debulking of a large right thigh plexiform neurofibroma under general anesthesia without neuromuscular blockade. The intraoperative course was notable for significant blood loss requiring transfusion and the development of transient generalized involuntary movements temporally associated with deep tumor manipulation. Despite these challenges, the procedure was successfully completed. This case highlights the anesthetic complexity of massive plexiform neurofibroma resection and underscores the importance of maintaining a broad differential diagnosis for intraoperative seizure-like phenomena in patients without epilepsy or intracranial pathology. Meticulous planning, multidisciplinary communication, and individualized anesthetic strategies are essential to optimize safety in complex neurofibromatosis type 1-related surgical procedures.
- Open Access
- 25 December 2025
- Published by Springer Nature in Cureus
- Vol. 17 (12)
Navigating the Crisis of White Cord Syndrome in a Diabetic Female Patient After Cervical Spine Surgery: A Case Report
We report the case of a 72-year-old woman with a medical history of asthma, hypothyroidism, and type 2 diabetes mellitus who underwent C4-C6 corpectomy with fibular osseous graft replacement and C2-T1 decompressive laminectomy with C2-T1 lateral fusion. The procedure also included posterior spinal fixation from C2 to T1 using transpedicular screws, along with decompressive laminectomies at the C2-T1 levels for symptomatic multilevel cervical stenosis. Intraoperatively, the patient developed a sudden loss of all neuromonitoring signals, consistent with an acute neurological insult. High-dose corticosteroids were administered to reduce inflammation and edema, and blood pressure was aggressively managed with vasopressors to maintain adequate mean arterial pressure. Despite these interventions, the patient demonstrated postoperative neurological deterioration. The patients’ motor strength improved in upper and lower extremities to 2/5 and 1/5, respectively, during evaluation in the postoperative care unit; however, neurological recovery plateaued during her subsequent stay in the neuro-intensive care unit, prompting transfer to an inpatient rehabilitation facility. In this case report, we present the intraoperative and postoperative management of an elderly diabetic patient who developed acute neurological deficits consistent with white cord syndrome (WCS) following cervical spine surgery, with particular emphasis on the interplay between perioperative hyperglycemia, high-dose corticosteroids, and WCS pathophysiology.
- 25 December 2025
- Published by Springer Nature in Cureus
- Vol. 17 (12)
Open AccessNavigating the Crisis of White Cord Syndrome in a Diabetic Female Patient After Cervical Spine Surgery: A Case Report
We report the case of a 72-year-old woman with a medical history of asthma, hypothyroidism, and type 2 diabetes mellitus who underwent C4-C6 corpectomy with fibular osseous graft replacement and C2-T1 decompressive laminectomy with C2-T1 lateral fusion. The procedure also included posterior spinal fixation from C2 to T1 using transpedicular screws, along with decompressive laminectomies at the C2-T1 levels for symptomatic multilevel cervical stenosis. Intraoperatively, the patient developed a sudden loss of all neuromonitoring signals, consistent with an acute neurological insult. High-dose corticosteroids were administered to reduce inflammation and edema, and blood pressure was aggressively managed with vasopressors to maintain adequate mean arterial pressure. Despite these interventions, the patient demonstrated postoperative neurological deterioration. The patients’ motor strength improved in upper and lower extremities to 2/5 and 1/5, respectively, during evaluation in the postoperative care unit; however, neurological recovery plateaued during her subsequent stay in the neuro-intensive care unit, prompting transfer to an inpatient rehabilitation facility. In this case report, we present the intraoperative and postoperative management of an elderly diabetic patient who developed acute neurological deficits consistent with white cord syndrome (WCS) following cervical spine surgery, with particular emphasis on the interplay between perioperative hyperglycemia, high-dose corticosteroids, and WCS pathophysiology.
- Open Access
- 17 August 2025
- Published by Springer Nature in Cureus
- Vol. 17 (8)
Anesthetic Considerations for and Management of a Parturient With Jarcho-Levin Syndrome: A Case Report of Continuous Spinal Anesthesia for Preterm Cesarean Section
Jarcho-Levin syndrome (JLS) is a rare congenital disorder marked by multiple vertebral abnormalities, a shortened spine, and rib fusion at the costovertebral junction. In addition to the typical physiological changes associated with pregnancy, patients with JLS face complications affecting their lungs, heart, spine, and mobility. Difficult airway management, pulmonary disease, and spinal deformities observed in these patients require a collaborative, multidisciplinary approach and meticulous perioperative planning. The presence of a challenging airway complicates the choice between general and neuraxial anesthesia. We present a case of a parturient with JLS who successfully underwent preterm cesarean delivery with continuous spinal anesthesia (CSA). After consultation with the multidisciplinary team, which included the Cardiology, Otolaryngology, and Obstetrics services, neuraxial anesthesia via a continuous spinal approach was chosen.
- 17 August 2025
- Published by Springer Nature in Cureus
- Vol. 17 (8)
Open AccessAnesthetic Considerations for and Management of a Parturient With Jarcho-Levin Syndrome: A Case Report of Continuous Spinal Anesthesia for Preterm Cesarean Section
Jarcho-Levin syndrome (JLS) is a rare congenital disorder marked by multiple vertebral abnormalities, a shortened spine, and rib fusion at the costovertebral junction. In addition to the typical physiological changes associated with pregnancy, patients with JLS face complications affecting their lungs, heart, spine, and mobility. Difficult airway management, pulmonary disease, and spinal deformities observed in these patients require a collaborative, multidisciplinary approach and meticulous perioperative planning. The presence of a challenging airway complicates the choice between general and neuraxial anesthesia. We present a case of a parturient with JLS who successfully underwent preterm cesarean delivery with continuous spinal anesthesia (CSA). After consultation with the multidisciplinary team, which included the Cardiology, Otolaryngology, and Obstetrics services, neuraxial anesthesia via a continuous spinal approach was chosen.
- Open Access
- 1 May 2025
- Published by Springer Nature in Cureus
- Vol. 17 (5)
Successful Anesthetic Management for Laparoscopic Gynecological Surgery in Adult-Onset Alexander’s Disease: A Case Report
Alexander's disease is a rare and progressive neurodegenerative disorder that presents significant challenges for anesthetic management due to its effects on the central nervous system. The disease stems from mutations in the glial fibrillary acidic protein (i.e., GFAP) gene, leading to impaired myelination and neurological complications such as bulbar dysfunction, spasticity, and autonomic instability. This case report presents the anesthetic management of a 34-year-old female patient diagnosed with Alexander's disease type II (i.e., adult-onset), cerebellar ataxia, and dysarthria. She underwent bilateral laparoscopic tubal sterilization and intrauterine device removal. After a thorough evaluation of the anesthetic options and consideration of the neurological complications associated with her condition, the procedure was successfully performed without complications under general anesthesia. To the best of our knowledge, this is the first documented case of a patient with Alexander’s disease type II undergoing a gynecological procedure under general anesthesia. This case highlights the complex considerations necessary in anesthetic care for patients with Alexander’s disease type II, including aspiration risk from bulbar dysfunction, altered response to neuromuscular blocking agents due to spasticity, and the potential for autonomic instability during surgical stimulation. Furthermore, it emphasizes the importance of a tailored anesthetic plan combined with vigilant perioperative monitoring in the management of these patients.
- 1 May 2025
- Published by Springer Nature in Cureus
- Vol. 17 (5)
Open AccessSuccessful Anesthetic Management for Laparoscopic Gynecological Surgery in Adult-Onset Alexander’s Disease: A Case Report
Alexander's disease is a rare and progressive neurodegenerative disorder that presents significant challenges for anesthetic management due to its effects on the central nervous system. The disease stems from mutations in the glial fibrillary acidic protein (i.e., GFAP) gene, leading to impaired myelination and neurological complications such as bulbar dysfunction, spasticity, and autonomic instability. This case report presents the anesthetic management of a 34-year-old female patient diagnosed with Alexander's disease type II (i.e., adult-onset), cerebellar ataxia, and dysarthria. She underwent bilateral laparoscopic tubal sterilization and intrauterine device removal. After a thorough evaluation of the anesthetic options and consideration of the neurological complications associated with her condition, the procedure was successfully performed without complications under general anesthesia. To the best of our knowledge, this is the first documented case of a patient with Alexander’s disease type II undergoing a gynecological procedure under general anesthesia. This case highlights the complex considerations necessary in anesthetic care for patients with Alexander’s disease type II, including aspiration risk from bulbar dysfunction, altered response to neuromuscular blocking agents due to spasticity, and the potential for autonomic instability during surgical stimulation. Furthermore, it emphasizes the importance of a tailored anesthetic plan combined with vigilant perioperative monitoring in the management of these patients.
- Open Access
- 26 March 2024
- Published by Springer Nature in Cureus
- Vol. 16 (3) , e56973
Acute Respiratory Failure Secondary to Low-Dose Opioid Administration in a Patient With Obstructive Sleep Apnea and Obesity Hypoventilation Syndrome After Undergoing Trans-sphenoidal Tumor Resection
We present a case of an obese 56-year-old male with obstructive sleep apnea (OSA), obesity hypoventilation syndrome (OHS), and pituitary macroadenoma, who underwent nasal endoscopic trans-sphenoidal resection. Surgery was performed under general anesthesia, uneventfully as planned. The patient experienced, however, delayed emergence despite receiving adequate neuromuscular blockade agent reversal. Extubation was performed and the patient was transferred to the recovery room on a Venturi mask (50% fraction of inspired oxygen, FIO2) and 93% saturation. Postoperatively, the patient was complaining of acute pain that did not resolve with non-opioid medications and a low morphine dose (0.035 mg/kg) for pain management was administered. Subsequently, he developed severe respiratory depression, requiring intubation. After three hours, the patient was extubated, transferred to the intensive care unit, and discharged five days later. Although the patient recovered favorably, this case highlights the risks of administering opioids to patients with OSA and OHS. To our knowledge, this is the first case reporting extreme respiratory depression secondary to the administration of a very low dose of morphine in patients with these comorbidities. Therefore, it is essential to be cautious with the use of opioids and to explore multimodal pain relief methods for these patients.
- 26 March 2024
- Published by Springer Nature in Cureus
- Vol. 16 (3) , e56973
Open AccessAcute Respiratory Failure Secondary to Low-Dose Opioid Administration in a Patient With Obstructive Sleep Apnea and Obesity Hypoventilation Syndrome After Undergoing Trans-sphenoidal Tumor Resection
We present a case of an obese 56-year-old male with obstructive sleep apnea (OSA), obesity hypoventilation syndrome (OHS), and pituitary macroadenoma, who underwent nasal endoscopic trans-sphenoidal resection. Surgery was performed under general anesthesia, uneventfully as planned. The patient experienced, however, delayed emergence despite receiving adequate neuromuscular blockade agent reversal. Extubation was performed and the patient was transferred to the recovery room on a Venturi mask (50% fraction of inspired oxygen, FIO2) and 93% saturation. Postoperatively, the patient was complaining of acute pain that did not resolve with non-opioid medications and a low morphine dose (0.035 mg/kg) for pain management was administered. Subsequently, he developed severe respiratory depression, requiring intubation. After three hours, the patient was extubated, transferred to the intensive care unit, and discharged five days later. Although the patient recovered favorably, this case highlights the risks of administering opioids to patients with OSA and OHS. To our knowledge, this is the first case reporting extreme respiratory depression secondary to the administration of a very low dose of morphine in patients with these comorbidities. Therefore, it is essential to be cautious with the use of opioids and to explore multimodal pain relief methods for these patients.
- Open Access
- 23 August 2023
- Published by Frontiers Media SA in Frontiers in Neurology
- Vol. 14, 1165155
Case report: A combination of nitroglycerin and adenosine proves effective in repairing a cerebral arteriovenous malformation
Hemorrhage secondary to rupture of a brain arteriovenous malformations (AVM) is one of the initial manifestations, and the main cause of, morbidity and mortality in patients with this condition. Current treatment strategies include endovascular embolization with the goal of AVM obliteration and neurological preservation. In the transvenous endovascular embolization procedure, adenosine is the preferred agent to induce temporary hypotension and allow adequate AVM embolization. We describe the intraoperative management of an adenosine-resistant 38 year-old male who underwent a successful intracranial AVM embolization after concomitant administration of gradually increasing doses of nitroglycerin. This report suggests that nitroglycerin infusion can be combined with adenosine boluses to create a pronounced and dose-dependent hypotension in patients partially unresponsive to adenosine alone.
- 23 August 2023
- Published by Frontiers Media SA in Frontiers in Neurology
- Vol. 14, 1165155
Open AccessCase report: A combination of nitroglycerin and adenosine proves effective in repairing a cerebral arteriovenous malformation
Hemorrhage secondary to rupture of a brain arteriovenous malformations (AVM) is one of the initial manifestations, and the main cause of, morbidity and mortality in patients with this condition. Current treatment strategies include endovascular embolization with the goal of AVM obliteration and neurological preservation. In the transvenous endovascular embolization procedure, adenosine is the preferred agent to induce temporary hypotension and allow adequate AVM embolization. We describe the intraoperative management of an adenosine-resistant 38 year-old male who underwent a successful intracranial AVM embolization after concomitant administration of gradually increasing doses of nitroglycerin. This report suggests that nitroglycerin infusion can be combined with adenosine boluses to create a pronounced and dose-dependent hypotension in patients partially unresponsive to adenosine alone.
- Open Access
- 13 June 2023
- Published by Springer Nature in Cureus
- Vol. 15 (6) , e40363
Anesthetic Management Including Postoperative Regional Anesthesia in a Young Adult Patient With Von Willebrand Disease and Osteogenesis Imperfecta
There are no established guidelines regarding anesthesia with a peripheral nerve block (PNB) in the young adult population with von Willebrand disease (vWD) type I. We present a case of a successful PNB outcome in a 20-year-old male patient with vWD type I, osteogenesis imperfecta (OI), and rheumatoid arthritis (RA) who underwent an intramedullary nailing surgery after suffering a left distal femur fracture secondary to a sports injury. Before the procedure, the patient was treated with HUMATE-P® [antihemophilic factor and von Willebrand factor (human)], ALPHANATE® (antihemophilic factor/von Willebrand factor complex), and aminocaproic acid for hematologic control. Left femoral and popliteal nerve blocks were performed for postoperative pain control. The patient was discharged home uneventfully three days after the surgery. In this case, PNB proved to be a safe and effective alternative in the management of a vWD type I young adult patient with comorbidities. Given the lack of established guidelines, a multidisciplinary team should be involved in the pre and perioperative management of these patients due to the risk of delayed bleeding.
- 13 June 2023
- Published by Springer Nature in Cureus
- Vol. 15 (6) , e40363
Open AccessAnesthetic Management Including Postoperative Regional Anesthesia in a Young Adult Patient With Von Willebrand Disease and Osteogenesis Imperfecta
There are no established guidelines regarding anesthesia with a peripheral nerve block (PNB) in the young adult population with von Willebrand disease (vWD) type I. We present a case of a successful PNB outcome in a 20-year-old male patient with vWD type I, osteogenesis imperfecta (OI), and rheumatoid arthritis (RA) who underwent an intramedullary nailing surgery after suffering a left distal femur fracture secondary to a sports injury. Before the procedure, the patient was treated with HUMATE-P® [antihemophilic factor and von Willebrand factor (human)], ALPHANATE® (antihemophilic factor/von Willebrand factor complex), and aminocaproic acid for hematologic control. Left femoral and popliteal nerve blocks were performed for postoperative pain control. The patient was discharged home uneventfully three days after the surgery. In this case, PNB proved to be a safe and effective alternative in the management of a vWD type I young adult patient with comorbidities. Given the lack of established guidelines, a multidisciplinary team should be involved in the pre and perioperative management of these patients due to the risk of delayed bleeding.
- 6 March 2023
- Published by S. Karger AG in Pharmacology
- Vol. 108 (3) , 265-273
Dantrolene Significantly Improves Cerebral Blood Flow in a Rat Model of Hemorrhagic Vasospasms
Introduction: A cerebral vasospasm (CVSP) is a potent vasoconstriction of the cerebral vasculature and the primary cause of morbidity and mortality following a subarachnoid hemorrhage. The middle cerebral artery (MCA) is commonly affected by CVSPs. Concomitant administration of dantrolene and nimodipine synergistically reduces vasospasms in aortic rings from Sprague Dawley rats. To determine if the effects observed in the systemic vasculature extend to the cerebral circulation, we investigated the effect of intravenous administration of dantrolene (2.5 mg/kg) and nimodipine (1 mg/kg and 2 mg/kg) on MCA blood flow velocity (BFV) 7 days after the induction of CVSPs. Methods: Vasospasms were induced by bathing the left common carotid artery with autologous whole blood. Age-matched sham rats were used as controls. BFV, mean arterial pressure (MAP), and heart rate (HR) were measured with a PeriFlux 5000 Laser Doppler System, and a CODA non-invasive blood pressure system, before and after administering the drugs. Morphometric evaluations were also performed to assess vascular alterations. Results: BFV was reduced by 37% with dantrolene alone (n = 6, p ≤ 0.05) and by 27% with 2 mg/kg nimodipine (n = 6, p < 0.05), while it was not affected by 1 mg/kg nimodipine. The combination of 1 mg/kg nimodipine with dantrolene, however, decreased BFV by 35% (from 435.70 ± 21.53 to 284.30 ± 23.13 perfusion units, n = 7, p ≤ 0.05). A similar reduction (31%) was obtained with dantrolene and 2 mg/kg nimodipine (from 536.00 ± 32.61 to 367.80 ± 40.93 perfusion units, n = 6, p ≤ 0.05). Neither MAP nor HR was affected by dantrolene or nimodipine alone. The combination of dantrolene with 2 mg/kg nimodipine, however, decreased MAP and increased HR. Furthermore, 7 days after the induction of vasospasms, lumen area of the left common carotid artery decreased, whereas media thickness and the wall-to-lumen ratio increased when compared to contralateral controls. The latter finding suggests that vascular remodeling was present at this stage. Conclusion: Altogether, our results indicate that 2.5 mg/kg dantrolene significantly reduces BFV in the MCA without altering systemic hemodynamic parameters to a similar extent than the highest dose of nimodipine or the combination of dantrolene and the lowest dose of nimodipine. Therefore, dantrolene may provide a promising alternative to lower the risk, or partially revert, CVSP.
- 6 March 2023
- Published by S. Karger AG in Pharmacology
- Vol. 108 (3) , 265-273
Dantrolene Significantly Improves Cerebral Blood Flow in a Rat Model of Hemorrhagic Vasospasms
Introduction: A cerebral vasospasm (CVSP) is a potent vasoconstriction of the cerebral vasculature and the primary cause of morbidity and mortality following a subarachnoid hemorrhage. The middle cerebral artery (MCA) is commonly affected by CVSPs. Concomitant administration of dantrolene and nimodipine synergistically reduces vasospasms in aortic rings from Sprague Dawley rats. To determine if the effects observed in the systemic vasculature extend to the cerebral circulation, we investigated the effect of intravenous administration of dantrolene (2.5 mg/kg) and nimodipine (1 mg/kg and 2 mg/kg) on MCA blood flow velocity (BFV) 7 days after the induction of CVSPs. Methods: Vasospasms were induced by bathing the left common carotid artery with autologous whole blood. Age-matched sham rats were used as controls. BFV, mean arterial pressure (MAP), and heart rate (HR) were measured with a PeriFlux 5000 Laser Doppler System, and a CODA non-invasive blood pressure system, before and after administering the drugs. Morphometric evaluations were also performed to assess vascular alterations. Results: BFV was reduced by 37% with dantrolene alone (n = 6, p ≤ 0.05) and by 27% with 2 mg/kg nimodipine (n = 6, p < 0.05), while it was not affected by 1 mg/kg nimodipine. The combination of 1 mg/kg nimodipine with dantrolene, however, decreased BFV by 35% (from 435.70 ± 21.53 to 284.30 ± 23.13 perfusion units, n = 7, p ≤ 0.05). A similar reduction (31%) was obtained with dantrolene and 2 mg/kg nimodipine (from 536.00 ± 32.61 to 367.80 ± 40.93 perfusion units, n = 6, p ≤ 0.05). Neither MAP nor HR was affected by dantrolene or nimodipine alone. The combination of dantrolene with 2 mg/kg nimodipine, however, decreased MAP and increased HR. Furthermore, 7 days after the induction of vasospasms, lumen area of the left common carotid artery decreased, whereas media thickness and the wall-to-lumen ratio increased when compared to contralateral controls. The latter finding suggests that vascular remodeling was present at this stage. Conclusion: Altogether, our results indicate that 2.5 mg/kg dantrolene significantly reduces BFV in the MCA without altering systemic hemodynamic parameters to a similar extent than the highest dose of nimodipine or the combination of dantrolene and the lowest dose of nimodipine. Therefore, dantrolene may provide a promising alternative to lower the risk, or partially revert, CVSP.
- Open Access
- 10 May 2021
- Published by Springer Nature in Scientific Reports
- Vol. 11 (1) , 1-9
The combination of dantrolene and nimodipine effectively reduces 5-HT-induced vasospasms in diabetic rats
Diabetics have a higher risk of developing cerebral vasospasms (CVSP) after subarachnoid hemorrhagic stroke than non-diabetics. Serotonin (5-HT) is one of the key vasoconstrictors released in the hemorrhagic blood and an important contributor to the etiology of CVSP. The combination of the ryanodine receptor blocker dantrolene and the Ca2+ channel blocker nimodipine significantly reduces phenylephrine (PHE)-induced vascular contraction in both diabetic and nondiabetic rats, but the effectiveness of this drug combination in reducing 5-HT-induced contraction is unknown. Dose–response curves for the 5-HT-induced contraction (from 0.1 nM to 100 µM) were performed on aortic rings from diabetic and non-diabetic rats after a 30-min incubation period with dantrolene, nimodipine, and both drugs in combination. In diabetic rats, 10 μM of dantrolene alone failed to reduce 5-HT-induced maximal contraction (Emax), but 50 μM reduced this parameter by 34% (n = 7, p < 0.05). In non-diabetic rats, by contrast, dantrolene did not modify the vascular response to 5-HT. 50 nM of nimodipine alone, however, reduced this parameter by 57% in diabetic rats (n = 10, p < 0.05), and by 34% in non-diabetic rats (n = 10, p < 0.05). In addition, concomitant administration of dantrolene and nimodipine reduced vascular reactivity to a similar extent in both diabetic (~ 60% reduction, n = 10, p < 0.05) and non-diabetic rats (~ 70% reduction, n = 10, p < 0.05). Moreover, the combination of nimodipine with the higher concentration of dantrolene significantly increased the EC50 values for the 5-HT-induced contraction curves in both diabetics (from 10.31 ± 1.17 µM to 19.26 ± 2.82; n = 10, p < 0.05) and non-diabetic rats (5.93 ± 0.54 µM to 15.80 ± 3.24; n = 10, p < 0.05). These results suggest that simultaneous administration of dantrolene and nimodipine has a synergistic effect in reducing 5-HT-induced vascular contraction under both diabetic and non-diabetic conditions. If our findings with rats are applicable to humans, concomitant administration of these drugs may represent a promising alternative for the management of CVSP in both diabetics and non-diabetics.
- 10 May 2021
- Published by Springer Nature in Scientific Reports
- Vol. 11 (1) , 1-9
Open AccessThe combination of dantrolene and nimodipine effectively reduces 5-HT-induced vasospasms in diabetic rats
Diabetics have a higher risk of developing cerebral vasospasms (CVSP) after subarachnoid hemorrhagic stroke than non-diabetics. Serotonin (5-HT) is one of the key vasoconstrictors released in the hemorrhagic blood and an important contributor to the etiology of CVSP. The combination of the ryanodine receptor blocker dantrolene and the Ca2+ channel blocker nimodipine significantly reduces phenylephrine (PHE)-induced vascular contraction in both diabetic and nondiabetic rats, but the effectiveness of this drug combination in reducing 5-HT-induced contraction is unknown. Dose–response curves for the 5-HT-induced contraction (from 0.1 nM to 100 µM) were performed on aortic rings from diabetic and non-diabetic rats after a 30-min incubation period with dantrolene, nimodipine, and both drugs in combination. In diabetic rats, 10 μM of dantrolene alone failed to reduce 5-HT-induced maximal contraction (Emax), but 50 μM reduced this parameter by 34% (n = 7, p < 0.05). In non-diabetic rats, by contrast, dantrolene did not modify the vascular response to 5-HT. 50 nM of nimodipine alone, however, reduced this parameter by 57% in diabetic rats (n = 10, p < 0.05), and by 34% in non-diabetic rats (n = 10, p < 0.05). In addition, concomitant administration of dantrolene and nimodipine reduced vascular reactivity to a similar extent in both diabetic (~ 60% reduction, n = 10, p < 0.05) and non-diabetic rats (~ 70% reduction, n = 10, p < 0.05). Moreover, the combination of nimodipine with the higher concentration of dantrolene significantly increased the EC50 values for the 5-HT-induced contraction curves in both diabetics (from 10.31 ± 1.17 µM to 19.26 ± 2.82; n = 10, p < 0.05) and non-diabetic rats (5.93 ± 0.54 µM to 15.80 ± 3.24; n = 10, p < 0.05). These results suggest that simultaneous administration of dantrolene and nimodipine has a synergistic effect in reducing 5-HT-induced vascular contraction under both diabetic and non-diabetic conditions. If our findings with rats are applicable to humans, concomitant administration of these drugs may represent a promising alternative for the management of CVSP in both diabetics and non-diabetics.